Cannabinoid Encyclopedia

Safety words

What does Drug interaction mean?

A safety topic connecting cannabinoids with medicines, enzymes, or clinical monitoring. 1

Also called: cyp enzymes, cyp interaction, drug interactions, medicine interaction

Simple definition

Drug interaction, in plain English

A safety topic connecting cannabinoids with medicines, enzymes, or clinical monitoring. 1

Why it matters

How this word is used in cannabinoid research

This word helps describe a possible risk, side effect, or interaction. The dose, product, route, and person still matter.

How to read it

Read the definition beside the study details, including dose, route, product, population, and outcome.

Read it in context

Three distinctions to keep visible

Use these checks before carrying the term into a conclusion. Return to the exact source whenever a mechanism label is doing important interpretive work or when study conditions differ. The related pages below contain the source-linked research record.

Research context: Systematic review of drug-drug interactions of delta-9-tetrahydrocannabinol, cannabidiol, and Cannabis Drug Interactions of Tetrahydrocannabinol and Cannabidiol in Cannabinoid Drugs

Reading check

Name both sides of the interaction

A useful interaction statement identifies the cannabinoid or product, the other medicine or substance, the amount and route, and the timing. A pathway-level concern or class-wide warning should not be rewritten as though every product and every medicine pair has been tested directly.

Reading check

Different evidence types answer different questions

Laboratory enzyme studies can identify a possible mechanism, pharmacokinetic studies can measure a change in exposure, and clinical reports can describe observed consequences. Those evidence layers are related but not interchangeable. The page should say which one the source actually measured.

Reading check

Personal medication decisions require clinical review

The size and importance of an interaction can depend on dose, formulation, timing, health status, other medicines, and the therapeutic range of the affected drug. Educational evidence can identify a reason for caution, but it should not instruct a reader to start, stop, or change a medicine without qualified clinical guidance.

Source checklist

What to verify before repeating the term

A precise definition is only the starting point. Use these checks to keep the source's assay, product, population, and conclusion attached to the word.

  1. 1

    Exact pair. Which cannabinoid or product, medicine, amount, route, schedule, and population were studied?

  2. 2

    Evidence type. Is the finding based on an enzyme assay, modeled prediction, pharmacokinetic study, case report, or controlled clinical outcome?

  3. 3

    Clinical relevance. Did the source measure only exposure or also adverse effects, efficacy changes, or another patient-relevant consequence?

Common questions

Questions people ask

What does Drug interaction mean?

A safety topic connecting cannabinoids with medicines, enzymes, or clinical monitoring.

Why does Drug interaction matter?

This word helps describe a possible risk, side effect, or interaction. The dose, product, route, and person still matter.

Is Drug interaction proof that a cannabinoid works?

No. A definition helps explain the language. The related research pages and their sources show what was actually studied.

What should I check when a source uses Drug interaction?

Check the exact pair, evidence type, clinical relevance. Then keep the exact compound or product, model or population, route, amount, timing, and measured outcome attached to the finding.

Sources

Research connected to this term

Definitions explain the word. These links show research records currently connected with it.

  1. 1
    Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis. insufficient PubMed 36206805
  2. 2
    Cannabidiol's impact on drug-metabolization. insufficient PubMed 37541924
  3. 3
    A Practical Guide to the Treatment of Dravet Syndrome with Anti-Seizure Medication. insufficient PubMed 35156171
  4. 4
    A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects. mechanistic or pharmacological PubMed 30374683
  5. 5
    Memantine for autism spectrum disorder. insufficient PubMed 36006807
  6. 6
    Consensus panel recommendations for the optimization of EPIDIOLEX® treatment for seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex. insufficient PubMed 39007525
See all 13 connected research sources
  1. 1
    Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis. insufficient PubMed 36206805
  2. 2
    Cannabidiol's impact on drug-metabolization. insufficient PubMed 37541924
  3. 3
    A Practical Guide to the Treatment of Dravet Syndrome with Anti-Seizure Medication. insufficient PubMed 35156171
  4. 4
    A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects. mechanistic or pharmacological PubMed 30374683
  5. 5
    Memantine for autism spectrum disorder. insufficient PubMed 36006807
  6. 6
    Consensus panel recommendations for the optimization of EPIDIOLEX® treatment for seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex. insufficient PubMed 39007525
  7. 7
    Antiseizure medications for Lennox-Gastaut Syndrome: Comprehensive review and proposed consensus treatment algorithm. insufficient PubMed 39854828
  8. 8
    Potential Adverse Drug Events and Drug-Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use. insufficient PubMed 31288397
  9. 9
    Clinical implications of trials investigating drug-drug interactions between cannabidiol and enzyme inducers or inhibitors or common antiseizure drugs. insufficient PubMed 32918835
  10. 10
    Distinct Interactions of Cannabinol and Its Cytochrome P450-Generated Metabolites with Receptors and Sensory Neurons. mechanistic or pharmacological PubMed 40568800
  11. 11
    Endocannabinoid metabolism by cytochrome P450 monooxygenases. insufficient PubMed 25461979
  12. 12
    Systematic review of drug-drug interactions of delta-9-tetrahydrocannabinol, cannabidiol, and Cannabis human systematic review PubMed 38868665
  13. 13
    Drug Interactions of Tetrahydrocannabinol and Cannabidiol in Cannabinoid Drugs clinical review PubMed 37874128